Synergistic control of sex hormones by 17β-HSD type 7: a novel target for estrogen-dependent breast cancer-Reference-Cited by-同舟云学术

Synergistic control of sex hormones by 17β-HSD type 7: a novel target for estrogen-dependent breast cancer

Published:2015-05-12 Issue:6 Volume:7 Page:568-579
ISSN:1674-2788
Container-title:Journal of Molecular Cell Biology
language:en
Short-container-title:J Mol Cell Biol

Author:

Wang Xiaoqiang,Gérard Catherine,Thériault Jean-François,Poirier Donald,Doillon Charles J.,Lin Sheng-Xiang

Publisher

Oxford University Press (OUP)

Subject

Cell Biology,Genetics,Molecular Biology,General Medicine

Link

http://academic.oup.com/jmcb/article-pdf/7/6/568/16836132/mjv028.pdf

Reference63 articles.

1. Adams J. Garcia M. Rochefort H. (1981). Estrogenic effects of physiological concentrations of 5-androstene-3 β, 17β-diol and its metabolism in MCF7 human breast cancer cells. Cancer Res. 41, 4720–4726.

2. Comparison of Functional Proteomic Analyses of Human Breast Cancer Cell Lines T47D and MCF7

3. Reductive 17β-hydroxysteroid dehydrogenases in the sulfatase pathway: Critical in the cell proliferation of breast cancer

4. 17β-Hydroxysteroid Dehydrogenase Type 1 Stimulates Breast Cancer by Dihydrotestosterone Inactivation in Addition to Estradiol Production

5. Cyclin D1 in Breast Cancer Pathogenesis

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Synthesis and characterization of targeted 17β-hydroxysteroid dehydrogenase type 7 inhibitors;The Journal of Steroid Biochemistry and Molecular Biology;2024-09

2. Targeting macrophagic 17β-HSD7 by fenretinide for the treatment of nonalcoholic fatty liver disease;Acta Pharmaceutica Sinica B;2023-01

3. Computational prediction and analysis of targeting 17-beta-hydroxysteroid dehydrogenase (17-beta-HSD1) with natural products for colorectal cancer treatment;Journal of Biomolecular Structure and Dynamics;2022-10-13

4. The Obesity-Related Metabolic Gene HSD17B8 Protects Against Breast Cancer: High RNA/Protein Expression Means a Better Prognosis;Medical Science Monitor;2021-11-25

5. The multi-specific human 17 beta-hydroxysteroid dehydrogenase type 7: Non-competitive inhibitors can target different catalyses to facilitate breast cancer treatment;The Journal of Steroid Biochemistry and Molecular Biology;2021-11